Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018:111:223-242.
doi: 10.1016/bs.apcsb.2017.11.001. Epub 2017 Dec 18.

Defining Pharmacological Targets by Analysis of Virus-Host Protein Interactions

Affiliations
Review

Defining Pharmacological Targets by Analysis of Virus-Host Protein Interactions

Manuel Llano et al. Adv Protein Chem Struct Biol. 2018.

Abstract

Viruses are obligate parasites that depend on cellular factors for replication. Pharmacological inhibition of essential viral proteins, mostly enzymes, is an effective therapeutic alternative in the absence of effective vaccines. However, this strategy commonly encounters drug resistance mechanisms that allow these pathogens to evade control. Due to the dependency on host factors for viral replication, pharmacological disruption of the host-pathogen protein-protein interactions (PPIs) is an important therapeutic alternative to block viral replication. In this review we discuss salient aspects of PPIs implicated in viral replication and advances in the development of small molecules that inhibit viral replication through antagonism of these interactions.

Keywords: Cellular cofactors; Protein complexes; Protein–protein interaction; Small organic molecules; Viral replication; Viruses; Virus–host interactome; Virus–host protein interactions.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Functional annotation of protein complexes from mammalian organisms reported in individual experiments complied in CORUM (10/16/2017; http://mips.helmholtz-muenchen.de/corum/#).

References

    1. Arkin M.R., Tang Y., Wells J.A. Small-molecule inhibitors of protein-protein interactions: Progressing toward the reality. Chemistry & Biology. 2014;21(9):1102–1114. doi: 10.1016/j.chembiol.2014.09.001. - DOI - PMC - PubMed
    1. Basse M.J., Betzi S., Morelli X., Roche P. 2P2Idb v2: Update of a structural database dedicated to orthosteric modulation of protein-protein interactions. Database (Oxford) 2016;2016 doi: 10.1093/database/baw007. - DOI - PMC - PubMed
    1. Berg M., Stenlund A. Functional interactions between papillomavirus E1 and E2 proteins. Journal of Virology. 1997;71(5):3853–3863. - PMC - PubMed
    1. Bhattacharya A., Alam S.L., Fricke T., Zadrozny K., Sedzicki J., Taylor A.B. Structural basis of HIV-1 capsid recognition by PF74 and CPSF6. Proceedings of the National Academy of Sciences of the United States of America. 2014;111(52):18625–18630. doi: 10.1073/pnas.1419945112. - DOI - PMC - PubMed
    1. Bordeleau M.E., Mori A., Oberer M., Lindqvist L., Chard L.S., Higa T. Functional characterization of IRESes by an inhibitor of the RNA helicase eIF4A. Nature Chemical Biology. 2006;2(4):213–220. doi: 10.1038/nchembio776. - DOI - PubMed

MeSH terms

LinkOut - more resources